CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results
Liora M. Schultz(Stanford University), Nikeshan Jeyakumar(Stanford University), Anne Marijn Kramer(Stanford University), Bita Sahaf(Stanford University), Hrishi Srinagesh(Stanford University), Parveen Shiraz(Stanford University), Neha Agarwal(Stanford University), Mark Hamilton(Stanford University), Courtney Erickson(Stanford University), Ashley Jacobs(Stanford University), Jennifer Moon(Stanford University), Christina Baggott(Stanford University), Sally Arai(Stanford University), Sushma Bharadwaj(Stanford University), Laura Johnston(Stanford University), Michaela Liedtke(Stanford University), Robert Lowsky(Stanford University), Everett Meyer(Stanford University), Robert S. Negrin(Stanford University), Andrew R. Rezvani(Stanford University), JUDY A. SHIZURU(Stanford University), Surbhi Sidana(Stanford University), Emily Egeler(Stanford University), Sharon Mavroukakis(Stanford University), Ramya Tunuguntla(Stanford University), Nikolaos Gkitsas-Long(Stanford University), Aidan Retherford(Stanford University), Annie Kathleen Brown(Stanford University), Anne-Louise Gramstrap-Petersen(Stanford University), Raquel Martin Ibañez(Stanford University), Steven A. Feldman(Stanford University), David B. Miklos(Stanford University), Crystal L. Mackall(Stanford University), Kara L. Davis(Stanford University), Matthew J. Frank(Stanford University), Sneha Ramakrishna(Stanford University), Lori Muffly(Stanford Blood Center)
Cited by 38Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis